X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Biocon Ltd with Dishman Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BIOCON LTD vs DISHMAN PHARMA - Comparison Results

BIOCON LTD    Change

Biocon is India's largest biotechnology company with presence in biopharmaceuticals, custom research and clinical research. It started as an enzymes manufacturer and later evolved into an integrated biopharmaceutical company. The company has two subs... More

DISHMAN PHARMA 
   Change

Dishman Pharmaceuticals is involved in the manufacture of APIs (active pharmaceutical ingredients), intermediates, quaternary compounds and fine chemicals. Besides this, the company is a significant player in the CRAMS (Contract Research and Manufact... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    BIOCON LTD DISHMAN PHARMA BIOCON LTD/
DISHMAN PHARMA
 
P/E (TTM) x 41.0 25.1 163.6% View Chart
P/BV x 7.1 3.3 212.9% View Chart
Dividend Yield % 0.2 0.7 24.5%  

Financials

 BIOCON LTD   DISHMAN PHARMA
EQUITY SHARE DATA
    BIOCON LTD
Mar-18
DISHMAN PHARMA
Mar-16
BIOCON LTD/
DISHMAN PHARMA
5-Yr Chart
Click to enlarge
High Rs1,188374 317.3%   
Low Rs305129 236.6%   
Sales per share (Unadj.) Rs68.7197.8 34.7%  
Earnings per share (Unadj.) Rs7.621.2 35.6%  
Cash flow per share (Unadj.) Rs14.034.7 40.2%  
Dividends per share (Unadj.) Rs1.002.00 50.0%  
Dividend yield (eoy) %0.10.8 16.9%  
Book value per share (Unadj.) Rs86.3179.9 48.0%  
Shares outstanding (eoy) m600.0080.69 743.6%   
Bonus/Rights/Conversions IS--  
Price / Sales ratio x10.91.3 853.8%   
Avg P/E ratio x98.911.9 833.0%  
P/CF ratio (eoy) x53.47.2 737.3%  
Price / Book Value ratio x8.61.4 618.0%  
Dividend payout %13.29.4 140.4%   
Avg Mkt Cap Rs m447,90020,306 2,205.8%   
No. of employees `0006.10.8 741.7%   
Total wages/salary Rs m9,3115,355 173.9%   
Avg. sales/employee Rs Th6,705.819,252.7 34.8%   
Avg. wages/employee Rs Th1,514.26,459.5 23.4%   
Avg. net profit/employee Rs Th736.92,064.1 35.7%   
INCOME DATA
Net Sales Rs m41,23415,961 258.4%  
Other income Rs m2,062265 776.9%   
Total revenues Rs m43,29616,226 266.8%   
Gross profit Rs m8,2914,103 202.1%  
Depreciation Rs m3,8511,091 353.1%   
Interest Rs m615944 65.1%   
Profit before tax Rs m5,8872,334 252.3%   
Minority Interest Rs m2130-   
Prior Period Items Rs m01 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,569624 251.6%   
Profit after tax Rs m4,5311,711 264.8%  
Gross profit margin %20.125.7 78.2%  
Effective tax rate %26.726.7 99.7%   
Net profit margin %11.010.7 102.5%  
BALANCE SHEET DATA
Current assets Rs m41,48611,018 376.5%   
Current liabilities Rs m21,4139,517 225.0%   
Net working cap to sales %48.79.4 517.7%  
Current ratio x1.91.2 167.3%  
Inventory Days Days64110 57.9%  
Debtors Days Days9435 270.3%  
Net fixed assets Rs m50,66116,304 310.7%   
Share capital Rs m3,000161 1,858.7%   
"Free" reserves Rs m48,80812,907 378.2%   
Net worth Rs m51,80814,516 356.9%   
Long term debt Rs m17,8984,189 427.2%   
Total assets Rs m99,89729,805 335.2%  
Interest coverage x10.63.5 304.6%   
Debt to equity ratio x0.30.3 119.7%  
Sales to assets ratio x0.40.5 77.1%   
Return on assets %5.28.9 57.8%  
Return on equity %8.711.8 74.2%  
Return on capital %9.617.5 55.0%  
Exports to sales %024.8 0.0%   
Imports to sales %03.7 0.0%   
Exports (fob) Rs mNA3,956 0.0%   
Imports (cif) Rs mNA596 0.0%   
Fx inflow Rs m12,0584,952 243.5%   
Fx outflow Rs m7,348697 1,054.5%   
Net fx Rs m4,7104,255 110.7%   
CASH FLOW
From Operations Rs m6,6212,786 237.6%  
From Investments Rs m-6,840-1,529 447.4%  
From Financial Activity Rs m-2,397-941 254.7%  
Net Cashflow Rs m-2,612316 -825.5%  

Share Holding

Indian Promoters % 40.4 61.4 65.8%  
Foreign collaborators % 20.6 0.0 -  
Indian inst/Mut Fund % 8.4 3.7 227.0%  
FIIs % 10.7 12.7 84.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 19.9 22.1 90.0%  
Shareholders   109,995 46,261 237.8%  
Pledged promoter(s) holding % 0.0 35.8 0.1%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare BIOCON LTD With:   ELDER PHARMA  FDC LTD.  SHASUN PHARMA  FRESENIUS KABI ONCO.  J.B.CHEMICALS  

Compare BIOCON LTD With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Where Will the Two-Faced Market Go from Here?(Podcast)

The stock markets are very volatile these days. As the Tanushree Bannerjee, the co-head of research here at Equitymaster puts it, stock markets are two-faced.

Related Views on News

BIOCON LTD Announces Quarterly Results (3QFY19); Net Profit Up 169.2% (Quarterly Result Update)

Jan 28, 2019 | Updated on Jan 28, 2019

For the quarter ended December 2018, BIOCON LTD has posted a net profit of Rs 2 bn (up 169.2% YoY). Sales on the other hand came in at Rs 15 bn (up 45.6% YoY). Read on for a complete analysis of BIOCON LTD's quarterly results.

BIOCON LTD Announces Quarterly Results (2QFY19); Net Profit Up 501.9% (Quarterly Result Update)

Nov 9, 2018 | Updated on Nov 9, 2018

For the quarter ended September 2018, BIOCON LTD has posted a net profit of Rs 4 bn (up 501.9% YoY). Sales on the other hand came in at Rs 13 bn (up 36.4% YoY). Read on for a complete analysis of BIOCON LTD's quarterly results.

BIOCON LTD Announces Quarterly Results (1QFY19); Net Profit Up 47.2% (Quarterly Result Update)

Jul 30, 2018 | Updated on Jul 30, 2018

For the quarter ended June 2018, BIOCON LTD has posted a net profit of Rs 1 bn (up 47.2% YoY). Sales on the other hand came in at Rs 11 bn (up 20.4% YoY). Read on for a complete analysis of BIOCON LTD's quarterly results.

BIOCON LTD Announces Quarterly Results (4QFY18); Net Profit Up 19.8% (Quarterly Result Update)

Jul 20, 2018 | Updated on Jul 20, 2018

For the quarter ended March 2018, BIOCON LTD has posted a net profit of Rs 2 bn (up 19.8% YoY). Sales on the other hand came in at Rs 12 bn (up 25.6% YoY). Read on for a complete analysis of BIOCON LTD's quarterly results.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

More Views on News

Most Popular

7 Stocks to Profit from Sensex 100,000(The 5 Minute Wrapup)

Feb 4, 2019

Tanushree Banerjee explains everything you need to know about the Rebirth of India and Sensex 100,000.

The RCom Bankruptcy: 5 Lessons for Smallcap Investors(Profit Hunter)

Feb 7, 2019

Managements of companies can create or ruin their fortunes. Why is management quality such an important factor in valuing businesses? Read on to find out...

Here's What the Biggest 'Rebirth of India' Investors are Doing(The 5 Minute Wrapup)

Feb 5, 2019

A roundtable on the 18th of January 2019 had investors with billions of dollars of investment kitty.

How We Pick the Most Profitable Stocks from the Portfolios of Super Investors(The 5 Minute Wrapup)

Feb 8, 2019

This is the trick to following super investors and not losing money.

Do You Have the Stomach to Survive a Small Cap Crash?(Profit Hunter)

Feb 5, 2019

While selecting good businesses is relatively easy task in a bearish phase, where most people fail is in having enough patience to hold the quality stocks until recovery.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

BIOCON LTD SHARE PRICE


Feb 15, 2019 (Close)

TRACK BIOCON LTD

  • Track your investment in BIOCON LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

BIOCON LTD - STERLING BIOTECH COMPARISON

COMPARE BIOCON LTD WITH

MARKET STATS